Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma.
Federico A, Steinfass T, Larribere L, Novak D, Moris F, Nunez LE, Umansky V, Utikal J
Mol Ther Oncolytics. 2020 Jun 4;18:83-99. doi: 10.1016/j.omto.2020.06.001. eCollection 2020 Sep 25.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.